These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27881503)

  • 21. Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.
    Rannanheimo PK; Tiittanen P; Hartikainen J; Helin-Salmivaara A; Huupponen R; Vahtera J; Korhonen MJ
    Value Health; 2015 Sep; 18(6):896-905. PubMed ID: 26409618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin efficacy in primary CVD prevention might diminish with patient age.
    Fernández-Ruiz I
    Nat Rev Cardiol; 2019 Apr; 16(4):200. PubMed ID: 30783252
    [No Abstract]   [Full Text] [Related]  

  • 23. Complete blood count risk score and its components, including RDW, are associated with mortality in the JUPITER trial.
    Horne BD; Anderson JL; Muhlestein JB; Ridker PM; Paynter NP
    Eur J Prev Cardiol; 2015 Apr; 22(4):519-26. PubMed ID: 24403296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MY APPROACH to Managing Statin-Associated Muscle Symptoms.
    Thompson PD
    Trends Cardiovasc Med; 2017 Feb; 27(2):160-161. PubMed ID: 28107840
    [No Abstract]   [Full Text] [Related]  

  • 25. Creating a conversation: insights from the development of a decision aid.
    Montori VM; Breslin M; Maleska M; Weymiller AJ
    PLoS Med; 2007 Aug; 4(8):e233. PubMed ID: 17683195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid Disorders: Screening and Treatment.
    Jin J
    JAMA; 2016 Nov; 316(19):2056. PubMed ID: 27838718
    [No Abstract]   [Full Text] [Related]  

  • 27. Reinitiation of statins after statin-associated musculoskeletal symptoms: a patient-centered approach.
    Brito JP; Montori VM
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):243-7. PubMed ID: 23481527
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacotherapy of dyslipidemias in the adult population.
    Vigna GB; Fellin R
    Expert Opin Pharmacother; 2010 Dec; 11(18):3041-52. PubMed ID: 20958118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dyslipidaemia and cardiovascular risk.
    Ryan A; Heath S; Cook P
    BMJ; 2018 Mar; 360():k835. PubMed ID: 30856096
    [No Abstract]   [Full Text] [Related]  

  • 30. Routine CAC-scoring prior to initiation of statin therapy - a European perspective.
    Mahabadi AA; Nasir K; Rassaf T
    Eur J Prev Cardiol; 2019 Sep; 26(14):1559-1561. PubMed ID: 30913900
    [No Abstract]   [Full Text] [Related]  

  • 31. Statins: numbers needed to treat and personal decision making.
    Bhopal RS
    BMJ; 2014 Aug; 349():g4980. PubMed ID: 25095785
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical misinformation: vet the message!
    Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen PS; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):62-63. PubMed ID: 30689786
    [No Abstract]   [Full Text] [Related]  

  • 33. [Limitations of the utilization of cardiovascular risk tables and statins].
    Palomo L; Sánchez-Robles G
    Med Clin (Barc); 2015 Apr; 144(7):334-5. PubMed ID: 25015254
    [No Abstract]   [Full Text] [Related]  

  • 34. Medical Misinformation: Vet the Message!
    Hill JA;
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):275-276. PubMed ID: 30863902
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipids, statins and cardiovascular disease.
    Cheifitz R
    Climacteric; 2008 Aug; 11(4):347-8; author reply 348-50. PubMed ID: 18645702
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances and emerging therapies in management of dyslipidemias.
    Pulipati VP; Davidson MH
    Trends Cardiovasc Med; 2021 Oct; 31(7):419-424. PubMed ID: 32858149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addressing key questions with statin therapy.
    Toth PP
    J Fam Pract; 2012 Jun; 61(6 Suppl):S34-9. PubMed ID: 22670245
    [No Abstract]   [Full Text] [Related]  

  • 39. [The discussion on target goals in lipid reduction is still going on. The Expert Committee--a block for current cardiovascular prevention].
    Olsson AG
    Lakartidningen; 2011 Nov 23-29; 108(47):2442-3. PubMed ID: 22468387
    [No Abstract]   [Full Text] [Related]  

  • 40. Shared Decision-Making and Patient Empowerment in Preventive Cardiology.
    Kambhampati S; Ashvetiya T; Stone NJ; Blumenthal RS; Martin SS
    Curr Cardiol Rep; 2016 May; 18(5):49. PubMed ID: 27098670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.